Nanoparticle surface charges alter blood-brain barrier integrity and permeability

被引:530
作者
Lockman, PR
Koziara, JM
Mumper, RJ
Allen, DD [1 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX 79106 USA
[2] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA
关键词
blood-brain barrier; electrostatic barrier; nanoparticles; emulsifying wax;
D O I
10.1080/10611860400015936
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose : The blood-brain barrier (BBB) presents both a physical and electrostatic barrier to limit brain permeation of therapeutics. Previous work has demonstrated that nanoparticles (NPs) overcome the physical barrier, but there is little known regarding the effect of NP surface charge on BBB function. Therefore, this work evaluated: (1) effect of neutral, anionic and cationic charged NPs on BBB integrity and (2) NP brain permeability. Methods : Emulsifying wax NPs were prepared from warm oil-in-water microemulsion precursors using neutral, anionic or cationic surfactants to provide the corresponding NP surface charge. NPs were characterized by particle size and zeta potential. BBB integrity and NP brain permeability were evaluated by in situ rat brain perfusion. Results : Neutral NPs and low concentrations of anionic NPs were found to have no effect on BBB integrity, whereas, high concentrations of anionic NPs and cationic NPs disrupted the BBB. The brain uptake rates of anionic NPs at lower concentrations were superior to neutral or cationic formulations at the same concentrations. Conclusions : (1) Neutral NPs and low concentration anionic NPs can be utilized as colloidal drug carriers to brain, (2) cationic NPs have an immediate toxic effect at the BBB and (3) NP surface charges must be considered for toxicity and brain distribution profiles.
引用
收藏
页码:635 / 641
页数:7
相关论文
共 41 条
[1]   Blood-brain barrier permeation models: Discriminating between potential CNS and non-CNS drugs including P-glycoprotein substrates [J].
Adenot, M ;
Lahana, R .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2004, 44 (01) :239-248
[2]   Characterization of the blood-brain barrier choline transporter using the in situ rat brain perfusion technique [J].
Allen, DD ;
Smith, QR .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (04) :1032-1041
[3]   Computation of the physio-chemical properties and data mining of large molecular collections [J].
Cheng, A ;
Diller, DJ ;
Dixon, SL ;
Egan, WJ ;
Lauri, G ;
Merz, KM .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2002, 23 (01) :172-183
[4]   Studies on the internalization mechanism of cationic cell-penetrating peptides [J].
Drin, G ;
Cottin, S ;
Blanc, E ;
Rees, AR ;
Temsamani, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (33) :31192-31201
[5]  
Fenart L, 1999, J PHARMACOL EXP THER, V291, P1017
[6]   Nanoparticles of biodegradable polymers for clinical administration of paclitaxel [J].
Feng, SS ;
Mu, L ;
Win, KY ;
Huang, GF .
CURRENT MEDICINAL CHEMISTRY, 2004, 11 (04) :413-424
[7]   Unexpected neurotoxicity of etoposide phosphate administered in combination with other chemotherapeutic agents after blood-brain barrier modification to enhance delivery, using propofol for general anesthesia, in a rat model [J].
Fortin, D ;
McCormick, CI ;
Remsen, LG ;
Nixon, R ;
Neuwelt, EA .
NEUROSURGERY, 2000, 47 (01) :199-207
[8]   Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles [J].
Gulyaev, AE ;
Gelperina, SE ;
Skidan, IN ;
Antropov, AS ;
Kivman, GY ;
Kreuter, J .
PHARMACEUTICAL RESEARCH, 1999, 16 (10) :1564-1569
[9]   The superfamily of organic anion transporting polypeptides [J].
Hagenbuch, B ;
Meier, PJ .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2003, 1609 (01) :1-18
[10]   ENDOTHELIAL NEGATIVE SURFACE-CHARGE AREAS AND BLOOD-BRAIN BARRIER FUNCTION [J].
HARDEBO, JE ;
KAHRSTROM, J .
ACTA PHYSIOLOGICA SCANDINAVICA, 1985, 125 (03) :495-499